2024 Update of the RECOVER-Adult Long COVID Research Index
Linda N. Geng(Palo Alto University), Juan P. Wisnivesky(General Department of Preventive Medicine), Judd E. Shellito(Louisiana State University), Tanayott Thaweethai(Harvard University), Nora G. Singer(MetroHealth Medical Center), Barbara S. Taylor(The University of Texas at San Antonio Health Science Center), Jason D. Goldman(University of Washington), Rachel Hess(University of Utah), Zaki A. Sherif(Howard University), Paul Goepfert(University of Maryland, Baltimore), Steven G. Deeks(University of California, San Francisco), Mario Castro(University of Kansas Medical Center), Monica Verduzco‐Gutierrez(The University of Texas Health Science Center at San Antonio), Caitlin Selvaggi(Massachusetts General Hospital), Logan Bartram(Icahn School of Medicine at Mount Sinai), Susan E. Hoover(Sanford Health), Matthew Modes(Cedars-Sinai Medical Center), Jonathan D. Klein(Andover Eye Associates), Athena Poppas(Brown University), Valerie J. Flaherman(University of California, San Francisco), Joyce Lee‐Iannotti(University of Arizona), Mady Hornig(Feinstein Institute for Medical Research), Emily B. Levitan(University of Alabama at Birmingham), Rebecca Letts, Stuart D. Katz(Andover Eye Associates), Jerry A. Krishnan(Chicago Department of Public Health), Jenny E. Han(Emory University), Jeanette P. Brown(University of Utah), Vincent C. Marconi(Emory University), Janko Ž. Nikolich(University of Arizona), Jake Scott(Stanford University), Hassan Ashktorab(Howard University Hospital), Shari B. Brosnahan(New York University), Torri D. Metz(Cornell University), Alexander W. Charney(Mount Sinai Medical Center), Megumi J. Okumura(University of California, San Francisco), Ornina Atieh(Case Western Reserve University), Peter Chen(Cedars-Sinai Medical Center), Richard M. Novak(Northwestern University), Sairam Parthasarathy(University of Arizona), Thomas F. Patterson(The University of Texas at San Antonio Health Science Center), Kristine M. Erlandson(University of Colorado Anschutz Medical Campus), Michael J. Peluso(San Francisco General Hospital), Ellie Hirshberg(Intermountain Healthcare), Hassan Brim(Howard University), Maher Ghamloush(Tufts Medical Center), Nathaniel Erdmann(University of Alabama), Igho Ofotokun(Emory University), J. Daniel Kelly(University of California, San Francisco)
Cited by 79
Related Papers
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
|New England Journal of Medicine|2018|1.9k
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
|New England Journal of Medicine|2020|1.1k
Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations
|Quality of Life Research|2011|942